Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-10 3:12 pm Sale | 2021-02-28 | 13G | Syros Pharmaceuticals, Inc. SYRS | ARK Investment Management LLC | 858,960 13.940% | -45,172 (-5.00%) | Filing History |
| 2021-02-16 4:33 pm Sale | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | ARK Investment Management LLC | 904,132 19.740% | -217,119 (-19.36%) | Filing History |
| 2021-02-16 3:12 pm Sale | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Point72 Asset Management, L.P. | 3,969 0.100% | -227,548 (-98.29%) | Filing History |
| 2021-02-11 5:27 pm Sale | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Nikko Asset Management Americas, Inc. | 438,199 9.570% | -59,267 (-11.91%) | Filing History |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | Syros Pharmaceuticals, Inc. SYRS | FMR LLC | 691,234 14.999% | 50,543 (+7.89%) | Filing History |
| 2021-02-05 06:10 am Sale | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Sumitomo Mitsui Trust Group Inc. | 438,199 9.570% | -59,267 (-11.91%) | Filing History |
| 2021-02-02 5:02 pm Sale | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | ARCH Venture Fund VII L.P. | 0 0.000% | -334,177 (Position Closed) | Filing History |
| 2021-02-01 08:23 am Purchase | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | BlackRock Inc. BLK | 332,556 7.300% | 46,215 (+16.14%) | Filing History |
| 2020-12-18 4:20 pm Purchase | 2020-12-08 | 13G | Syros Pharmaceuticals, Inc. SYRS | Ally Bridge MedAlpha Master Fund L.P. | 303,313 5.400% | 303,313 (New Position) | Filing History |
| 2020-12-14 5:12 pm Purchase | 2020-12-08 | 13G | Syros Pharmaceuticals, Inc. SYRS | Bain Capital Life Sciences Fund II, L.P. | 578,504 11.000% | 578,504 (New Position) | Filing History |
| 2020-10-09 2:16 pm Purchase | 2020-06-30 | 13G | Syros Pharmaceuticals, Inc. SYRS | ARK Investment Management LLC | 1,121,251 24.500% | 613,470 (+120.81%) | Filing History |